Tenax Therapeutics Inc. (TENX)
NASDAQ · Healthcare
Tenax Therapeutics Inc. EBITDA 2011–2025
Tenax Therapeutics Inc. annual/quarterly ebitda history and growth rate from 2011 to 2014. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Tenax Therapeutics Inc. ebitda for the quarter ending July 31, 2014 was -2.4 M, a 53.18% increase year-over-year.
- Tenax Therapeutics Inc. ebitda for the twelve months ending July 31, 2014 was -7.9 M.
- Tenax Therapeutics Inc. annual ebitda for 2024 was -19.5 M, a 62.96% decrease from 2016.
- Tenax Therapeutics Inc. annual ebitda for 2016 was -52.6 M, a 258.81% increase from 2015.
- Tenax Therapeutics Inc. annual ebitda for 2015 was -14.7 M, a 10.89% decrease from 2014.
- Tenax Therapeutics Inc. annual ebitda for 2014 was -16.5 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tenax Therapeutics Inc. EBITDA — FAQ
Tenax Therapeutics Inc. (TENX) ebitda over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TENX's ebitda history?
The chart and table above show Tenax Therapeutics Inc.'s ebitda by year and by quarter, including the growth rate.